On-line near-infrared spectroscopy optimizing and monitoring biotransformation process of γ-aminobutyric acid  by Ding, Guoyu et al.
Journal of Pharmaceutical Analysis 6 (2016) 171–178H O S T E D  B Y Contents lists available at ScienceDirectjournal homepage: www.elsevier.com/locate/jpa
Journal of Pharmaceutical Analysishttp://d
2095-17
(http://c
☆Peer
n Corr
Tianjin
E-mwww.sciencedirect.comOriginal ArticleOn-line near-infrared spectroscopy optimizing and monitoring
biotransformation process of γ-aminobutyric acid$
Guoyu Ding, Yuanyuan Hou n, Jiamin Peng, Yunbing Shen, Min Jiang, Gang Bai
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Nankai University; Tianjin Key Laboratory of Molecular Drug Research, Nankai
University, Tianjin 300071, Chinaa r t i c l e i n f o
Article history:
Received 14 August 2015
Received in revised form
14 January 2016
Accepted 4 February 2016
Available online 6 February 2016
Keywords:
Near-infrared spectroscopy
L-glutamic acid
γ-aminobutyric acid
Box-Behnken design
Glutamate decarboxylasex.doi.org/10.1016/j.jpha.2016.02.001
79/& 2016 Xi'an Jiaotong University. Producti
reativecommons.org/licenses/by-nc-nd/4.0/).
review under responsibility of Xi'an Jiaotong
espondence to: College of Pharmacy, Nankai
300071, China.
ail address: houyy@nankai.edu.cn (Y. Hou).a b s t r a c t
Near-infrared spectroscopy (NIRS) with its fast and nondestructive advantages can be qualiﬁed for the
real-time quantitative analysis. This paper demonstrates that NIRS combined with partial least squares
(PLS) regression can be used as a rapid analytical method to simultaneously quantify L-glutamic acid (L-
Glu) and γ-aminobutyric acid (GABA) in a biotransformation process and to guide the optimization of
production conditions when the merits of NIRS are combined with response surface methodology. The high
performance liquid chromatography (HPLC) reference analysis was performed by the o-phthaldialdehyde
pre-column derivatization. NIRS measurements of two batches of 141 samples were ﬁrstly analyzed by
PLS with several spectral pre-processing methods. Compared with those of the HPLC reference analysis,
the resulting determination coefﬁcients (R2), root mean square error of prediction (RMSEP) and residual
predictive deviation (RPD) of the external validation for the L-Glu concentration were 99.5%, 1.62 g/L, and
11.3, respectively. For the GABA concentration, R2, RMSEP, and RPD were 99.8%, 4.00 g/L, and 16.4, re-
spectively. This NIRS model was then used to optimize the biotransformation process through a Box-
Behnken experimental design. Under the optimal conditions without pH adjustment, 200 g/L L-Glu could
be catalyzed by 7148 U/L glutamate decarboxylase (GAD) to GABA, reaching 99% conversion at the ﬁfth
hour. NIRS analysis provided timely information on the conversion from L-Glu to GABA. The results
suggest that the NIRS model can not only be used for the routine proﬁling of enzymatic conversion,
providing a simple and effective method of monitoring the biotransformation process of GABA, but also
be considered to be an optimal tool to guide the optimization of production conditions.
& 2016 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
γ-aminobutyric acid (GABA) is an important non-protein
component amino acid that is applied in various ﬁelds such as
food [1], medical healthcare [2], and chemical engineering [3].
GABA has received growing attention in the medical healthcare
ﬁeld due to its inhibitory effects on central nervous system, in-
cluding sedation, anti-depression, anti-insomnia, anti-hyperten-
sive and diuretic effects [4–6]. It can be produced by several
methods such as plant tissue enrichment [7], microbial fermen-
tation [8] and biotransformation [9], and can be transformed by
Escherichia coli (E. coli), genetically engineered strain expressing
high levels of glutamate decarboxylase (GAD, EC4.1.1.15). By the
enzymatic synthesis strategy (Fig. 1), the production of GABAon and hosting by Elsevier B.V. Th
University.
University, 94 Weijin Road,has higher concentration and purity. Although the amino acid
enzymatic conversion strategy is easy to operate, it is not possible
to ensure that the enzymatic activity remains constant, as strain
passage and culture conditions can lead to some differences.
If the enzymatic activity is too high, it will be a waste of the
enzyme using the same biomass. When the enzymatic activity is
too low, the transformation rate will decrease, which decreases
the product purity and production efﬁciency due to the unclear
endpoint of the biotransformation process [10]. Therefore, a proper
process-monitoring method is beneﬁcial for the programmed pro-
duction of GABA.
Processional analytical technology (PAT) is deﬁned as “systems
for continuous analysis and control of manufacturing processes
based on real-time, or rapid measurements during processing, of
quality and performance attributes of raw and in-process materials
and processes to ensure end product quality at completion of the
process” by the United States Food and Drug Administration
(USFDA). To ensure product quality, FDA suggests that the in-
troduction of PAT can provide quality control during processing,is is an open access article under the CC BY-NC-ND license
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Fig. 1. Reaction equation of biotransformation from L-Glu to GABA.
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to ensure end product quality at the end of the process. In parti-
cular, near-infrared spectroscopy (NIRS) is an advanced analytical
technology that has recently been highly developed in the PAT
ﬁeld [11–13]. Because NIRS has many merits such as simple op-
eration (no sample pretreatment), rapid measurement, no pollu-
tion, providing a large amount of information (physical and che-
mical properties can be determined with simple one time scan-
ning and without damaging samples) [14]. Due to these ad-
vantages, NIRS has been introduced to the pharmaceutical, food,
chemical engineering, textile, petroleum, and vintage industries
[15–21]. For example, NIRS was investigated as a PAT to monitor
amino acid concentration proﬁles during the hydrolysis of Cornu
Bubali [22]. In this research, a NIRS model was developed using
interval partial least squares and synergy interval partial least
squares to monitor 11 different amino acids. A new parameter
desirability index and multivariate quantiﬁcation limit (MQL) va-
lues were used to evaluate the NIRS model. Excellent accuracies
and low MQL values were obtained for L-proline, L-tyrosine, L-va-
line, L-phenylalanine and L-lysine. The results conﬁrmed that these
models are suitable to improve hydrolysis efﬁciency, and enabled a
reduction in hydrolysis time, which directly affects process
productivity.
Almost all types of compounds and mixtures can be quantiﬁed
by NIRS with the chemometrics method. In this study, the opti-
mization of the GABA enzymatic synthesis and monitoring of the
biotransformation process both required multiple points testing
and rapid results feedback. NIRS with its fast and nondestructive
advantages will be qualiﬁed for the real-time quantitative analysis.
It can provide guidance to determine whether the production
process of GABA biotransformation is performing consistently
with expectations, and rapid analysis at the end of the biological
reaction. In this study, multivariate models were developed to
quantify L-Glu and GABA levels that had previously been de-
termined by pre-column derivatization high performance liquid
chromatography (HPLC), and then partial least squares (PLS) re-
gression prediction models with NIRS were constructed. After
evaluating the stability, a new batch of samples was used for ex-
ternal validation to monitor biotransformation. Then, a Box-
Behnken experimental design was used to optimize the process
parameters using the NIRS model. Finally, the best process con-
ditions were used for the GABA biotransformation process with
on-line NIRS monitoring.2. Materials and methods
2.1. Instruments
Analysis was carried out on an Agilent–1200 HPLC system
(Agilent Technologies, Waldbronn, Germany) equipped with a
quaternary pump (G1311C), on-line degasser (G1322A), auto-
sampler (G1229A), thermo column compartment (G1316A) and
photo-diode-detector (G4212A). Near-infrared diffuse reﬂectance
spectra were acquired using a Bruker TENSOR 37 FT-NIR spectro-
meter (Bruker Optik, Ettlingen, Germany) with an InGaAs detector
and an Integrating Sphere Module over the wavenumber range of
12,000–4000 cm1.The biotransformation process was carried out in a 15 L glass
tank bioreactor (Applikon Biotechnology, Delft, the Netherlands).
The GAD genetically engineered super producer E. coli strain was
cultivated in a 150 L fermenter (Biotech–2002 Bioprocess Con-
troller, Baoxing, Shanghai, China).
2.2. Chemicals and materials
HPLC-grade acetonitrile and methanol were purchased from
Merck (Darmstadt, Germany). Deionized water was prepared by a
Milli-Q water system (Millipore, Bedford, MA, USA) to prepare
samples and the mobile phase. Other reagents were of analytical
grade, and were purchased from Concord Technology (Tianjin,
China). All solvents were ﬁltered through 0.22 μm membrane ﬁl-
ters before analysis.
The reference standards (GABA and L-Glu) and the coenzyme
pyridoxal 5′-phosphate (PLP) were obtained from Sigma-Aldrich
(St. Louis, MO, USA). The purities of all of the standards were not
less than 98%. The L-Glu, yeast extract and tryptone used in fer-
mentation and biotransformation were purchased from Teda Letai
Chemical Co., Ltd (Tianjin, China).
2.3. Cultivation of genetically engineered strain
The GAD high-expression strain of E. coli BL21 (NK-GAD402)
was obtained from earlier work in our laboratory. The E. coli strain
(NK-GAD402) was grown at 37 °C in a fermenter with 100 L of
nutrient medium with the following composition: 5.0 g/L of yeast
extract, 10 g/L of NaCl, 10 g/L of tryptone and up to 65 L of tap
water (pH 7.2). The mixer rotation speed was 300 rpm, and the
ﬂow rate of sterile air was 15 L/min. When the optical density of
the culture medium reached 1.0 at 600 nm, approximately 5 L of a
200 g/L lactose solution was fed into the fermentation broth. After
4 h of lactose induction, approximately 500 g of the GAD high-
expression strain was obtained through centrifugation
(3000 rpm). The obtained biomass was redissolved in water to
obtain a concentration of 200 g/L and frozen at 20 °C.
The enzymatic activity of GAD was expressed in U/g cells (wet
weight) and determined according to a previously developed
method with slight modiﬁcation [23]. One unit (U) of GABA-
forming activity was deﬁned as the amount of enzyme that
liberates 1 μM GABA per minute in the following activity assay
mixture. To start the reaction, 5 mL of 10 mg/mL biomass (wet
weight) was added into the reaction mixture containing 35 g/L
sodium glutamate, 200 mM Macilvaine buffer and 0.02 mM PLP at
pH 4.35. After incubation at 37 °C for 30 min, the reaction was
terminated by dilution in boric acid buffer (0.4 M, pH 10.2). The
supernatant was obtained by centrifugation at 12,000 rpm for
10 min at room temperature and was then subjected to HPLC
analysis.
2.4. Biotransformation of L-glutamic acid
Improving the cell wall permeability can increase the chance of
substrate access to intracellular enzymes, increasing the conver-
sion efﬁciency. To undergo thermal activation, the strain NK-
GAD402 biomass was stored in a 20 °C freezer and then pre-
incubated in a 37 °C water bath before use. L-Glu (2 kg) and PLP
(50 mg) were then added into 10 L of water. Initially, 1200 U/L GAD
high-expression strain (NK-GAD402) and 1 mL organic foam sup-
pressor were added to the reaction environment. One hour later,
fed-batch processing began at 660 U/L/h biomass, lasting for 8 h.
The ﬁrst sample was collected after 20 min. From that time on,
samples were obtained every 10 min up to 12 h from the begin-
ning of reaction. A total of 141 samples were obtained from two
fermentation trials. The ﬁrst batch of samples was used for
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2.5. Preparation of standard and sample solutions
To determine the concentration of L-Glu and GABA in the bio-
transformation process, 100 μL sample was collected from the
bioreactor, diluted with 25 or 50 mL boric acid buffer (0.4 M, pH
10.2) to stop the enzymatic reaction, and prepared for HPLC
analysis.
L-Glu and GABA reference compounds were accurately
weighed, dissolved in 1% hydrochloric acid, and diluted to an ap-
propriate concentration with the boric acid buffer. A mixed stan-
dard solution was prepared in 1% hydrochloric acid. All solutions
were stored in a refrigerator at 4 °C and allowed to warm to room
temperature before analysis. The o-Phthaldialdehyde (OPA) solu-
tion was prepared by mixing 100 mg of OPA, 9 mL of boric acid
buffer, 1 mL of acetonitrile and 130 μL of 2-mercaptoethanol. After
mixing, the OPA solution was passed through a 0.45 μm syringe
ﬁlter.
2.6. Derivatization procedure and chromatographic conditions
Solution A was prepared with 0.8 g/L sodium acetate and
0.022% triethylamine in water, adjusted to pH 7.2070.05 with 5%
(v/v) acetic acid. And the sodium acetate buffer was prepared with
0.8 g/L sodium acetate in water, adjusted to pH 7.2070.05 with 2%
(v/v) acetic acid. Solution B was blended together at the ratio of
2:2:1 with acetonitrile, methanol and the sodium acetate buffer.
The auto-sampler was programmed to mix 20 μL standard or
sample solution with 1 μL of the OPA reagent solution and 9 μL of
boric acid solution for 1 min in the derivatization loop. After the
OPA mixtures were injected into the HPLC column, a solvent gra-
dient was initiated.
The analysis was performed on a Phenomenex Luna reversed-
phase C18 column (250 mm4.6 mm, 5 μm) and maintained at
25 °C. The mobile phase was a mixture of solution A and solution B
according to the following gradient: 0 min, 20% B; 3 min, 30% B;
7–12 min, 100% B; and 14–17.3 min, 20% B. Elution was performed
at a solvent ﬂow rate of 1.0 mL/min, and chromatograms were
collected at 338 nm by the PDA detector. The injection volume was
10 μL for each sample and standard solution.
2.7. Multivariate calibration model
2.7.1. NIRS
NIRS were acquired using a Brucker TENSOR 37 FT-NIR spec-
trometer (Bruker Optik, Ettlingen, Germany) over the wavenumber
range of 12000 to 4000 cm1. A cuvette of 2 mm thickness was
applied for the transmission spectrum research with a resolution
of 8 cm1 by averaging over 32 scans. Temperature and relative
humidity remained approximately 23 °C and 55%, respectively. A
background spectrum was collected for water. Triplicate spectra
were collected consecutively for each sample.
2.7.2. Spectral pre-processing
To achieve the best prediction performance, several spectral
pre-processing techniques were investigated using the Bruker
TENSOR 37 SYSTEM OPUS 7.0 Edition (Bruker Optics, Ettlingen,
Germany). The spectral pre-processing methods included constant
offset elimination, straight line subtraction, standard normal
variate transformation (SNV), min–max normalization, multi-
plicative scatter correction (MSC), ﬁrst derivative (Der1), second
derivative (Der2), Der1þstraight line subtraction, Der1þSNV and
Der1þMSC.2.7.3. PLS calibration
PLS regression is a powerful method of revealing the linear re-
lationship between spectra (X) and parameters under investigation
(Y) [24]. During PLS analysis, both X and Y matrices are ﬁrst trans-
formed into new spaces, and the obtained X and Y scores are then
carefully selected and correlated in an attempt to maximize the
interpretation of Y scores based on X scores. Subsequently, the
predicted Y scores are used to predict Y. Collected spectra were
analyzed using PLS regression analysis built-in OPUS 7.0. To select
the calibration model parameters including the number of PLS
factors and the pre-processing method, optimal conditions were
determined for the calibration set with the lowest root mean square
error of cross validation (RMSECV). Once these conditions were
determined for the calibration set, the validation samples were
returned to the calibration set, and the same calibration parameters
were used to establish PLS models. As a validation set is employed,
model parameters are independent of the external validation data
set, which should produce more robust calibration models that are
less dependent on the speciﬁc samples employed. Each sample
spectrum was collected in triplicate to reduce any machine de-
pendent effects.
The spectra from the ﬁrst batch of biotransformation were
sorted by sampling time for the 71 samples used as a calibration
set. All of the 70 samples from the second batch were used as a
validation set.
2.7.4. Model assessment
To assess the model developed here, determination coefﬁcients
(R2), RMSECV, residual predictive deviation (RPD) and root mean
square error of prediction (RMSEP) were computed to evaluate the
performance. These parameters are deﬁned as follows:
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where yi,predicted is the predicted Glu/GABA result, yi,actual is the Glu/
GABA reference result, and yaverage represents the average of the
reference results of all samples. n is the number of samples for
calibration and m is the number of samples for validation or ex-
ternal validation. SD is the standard deviation of the reference
results of all samples in the validation.
2.8. Box-Behnken design
Design expert 7.0 software was used to generate the matrix and
analyze the response surface models. A 3-level, 3-factor Box-
Behnken design was selected for this study because it can evaluate
quadratic interactions between pairs of factors while minimizing
the number of required experiments. The inﬂuences of interac-
tions among three factors, i.e., total enzymatic activity, total time
of enzyme addition and reaction time, were examined in this
study. A total of 17 experiments were performed to test the effects
of these factors. The two responses (GABA content and the initial
Table 1
Factors and levels for the Box-Behnken experimental design.
Factors Code Level
1 0 1
Total enzymatic activity (U/L) A 3330 6660 13,320
Total time of enzyme addition (h) B 1.5 3 6
Reaction time (h) C 3 4 5
Table 2
Calibration curves of L-Glu and GABA.
Analytes Calibration curve R2 Linear range
(g/L)
LOQ (g/L) LOD (g/L)
L-Glu Y¼53,267X40.076 0.9989 0.005–0.2 0.0015 0.0005
GABA Y¼41,666X3.186 0.9987 0.005–0.2 0.0024 0.0008
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experiment. The coded design patterns represent the scaled factor
values (high (1), middle (0) and low (1)) used in each run, in the
order of total enzymatic activity, total time of enzyme addition and
reaction time, respectively (Table 1). The responses were predicted
by the NIRS model constructed in Section 2.5.
To verify the reliability of the resulting model, tests were per-
formed using the optimal process parameters. This third batch
acted as the model validation.3. Results and discussion
3.1. HPLC analysis of L-Glu and GABA
With the developed pre-column derivatization HPLC method, L-
Glu and GABA were separated and identiﬁed according to their
retention time (Fig. 2); good linearity of each marker component
was observed over a relatively wide concentration range (0.005–
0.2 g/L) with a correlation coefﬁcient above 0.99, and the limit of
determination (LOD) and limit of quantitation (LOQ) are also listed
in Table 2. The precision, reproducibility, and accuracy of this
method were also satisfactory.
3.2. Raw and pre-processing spectral analysis
Fig. 3A presents the raw NIR spectra of samples taken from the
GABA biotransformation at wavenumbers ranging from 9000 to
4000 cm1. After Der1 pretreatment of the raw NIR spectra,
several characteristic absorption peaks can be observed in Fig. 3B,
including 8780 and 8600 cm1 due to the second overtone of the
C–H stretching vibration and the combination of the ﬁrst overtone
of the C–H stretching and deformation vibrations; 7180 cm1 due
to the combination of the ﬁrst overtone of the C–H stretching and
C–H fundamental deformation vibrations; 6790 cm1 due to the
ﬁrst overtone of the N–H stretching vibration; 6000, 5940, 5820,
5800, and 5650 cm1 due to the ﬁrst overtone of C–H stretching;
4640 cm1 due to the combination of N–H fundamental stretching
and deformation vibrations; and 4480, 4400, and 4340 cm1 dueFig. 2. HPLC proﬁling of a mixed standard solution.to the combination of C–H fundamental stretching and deforma-
tion vibrations [25–27]. These signals could arise from CH2 and
NH2 bonds in L-Glu and GABA, the two main compounds in the
broth, indicating that NIRS can reﬂect the chemical information of
the samples and monitor the biotransformation process.
3.3. Development of a PLS multivariate calibration model
Multivariate calibration models have several important para-
meters, including wavelength range, spectral pretreatment method
and latent variables (LVs). Generally, optimal model parameters
depend on the lowest RMSEP and higher RPD with lower LVs. In
this study, automatic optimization software (OPUS 7.0) was used
to obtain the best model by an optimized spectral pretreatment
method, with LVs over the wavelength range without noise com-
ponents (12,000–5300 and 4872–4224 cm1). The optimization
results showed that the traditional spectral pretreatments, SNV
and MSC, were not suitable for the development of a multivariate
calibration model to determine L-Glu and GABA in the bio-
transformation process (Table 3). As SNV and MSC are used to
eliminate the scattering effects produced by heterogeneous dis-
tributions and irregular particle forms, they are normally used to
analyze the diffuse reﬂection of solid samples and the transmis-
sion reﬂection of slurry substances [28]. Different pretreatments
were tested. The adopted pretreatment was Der1, which was cal-
culated using nine data points and smoothed using Savitzky and
Golay polynomial smoothing on nine data points for the whole
data set. L-Glu and GABA shared the same spectral pretreatment,
probably due to their similar chemical structures.
The number of LVs was selected based on the minimization of
the RMSECV, which corresponds to the predictive error obtained in
the cross-validation stage. This step is similar to the cross-valida-
tion, wherein a parameter based on the division of the calibration
is divided into subgroups, and each subgroup is sequentially re-
moved for inclusion in the predictive set. The introduction of the
seven LVs minimized the RMSECV value of GABA and L-Glu. With
Der1 spectral pretreatment under seven LVs, the second batch of
biotransformation samples was used as the validation set to test
the stability of the PLS model ( Fig. 4).
The RPD was used to evaluate how well the calibration model
predicted compositional data. The RPD is deﬁned as the SD of the
population's reference values divided by the RMSEP for the NIRS
calibrations. High RPD values indicate that the calibration model
exhibits robust predictive ability. Generally, RPD values ranging
from three to ﬁve are considered sufﬁcient for application pur-
poses, and the RPD value of ﬁve is considered to be good for
quality monitoring [29]. The RPD values of the PLS calibration
models for the GABA and L-Glu concentrations were 16.4 and 11.3,
respectively (Table 3). The ﬁtting plots of the predicted versus
experimental values based on the validation set are presented in
Fig. 5. These results indicate that these two calibration models can
be used to reliably predict the GABA and L-Glu concentrations
during the biotransformation process.
3.4. Optimization of biotransformation conditions
The aim of the optimization of biotransformation is typically to
Fig. 3. (A) original NIR spectra and (B) Der1-preprocessed original spectra of samples taken from GABA biotransformation.
Table 3
Effects of spectral pretreatments and latent variables on the PLS models of GABA and L-Glu.
Spectral pretreatments LVs GABA LVs L-Glu
RMSECV (g/L) R2 (%) RMSEP (g/L) RPD RMSECV (g/L) R2 (%) RMSEP (g/L) RPD
Raw 9 1.56 99.9 5.25 15.0 8 0.97 99.5 6.17 14.9
Constant offset elimination 9 1.47 99.9 7.07 15.1 8 0.91 99.6 6.26 15.1
Straight line subtraction 8 1.74 99.9 3.16 14.3 6 0.96 99.5 1.82 14.7
SNV 13 4.62 99.0 29.3 3.76 13 1.83 98.2 6.80 2.65
Min–max normalization 12 4.82 98.9 18.6 3.13 15 2.15 97.5 7.12 2.47
MSC 11 5.02 98.8 26.6 2.43 14 3.09 94.9 17.9 0.88
Der1 7 2.02 99.8 4.00 16.4 7 0.95 99.5 1.62 11.3
Der2 5 2.11 99.8 5.42 12.5 12 1.09 99.4 3.09 7.87
Der1þstraight line subtraction 6 1.96 99.8 4.89 16.4 6 1.00 99.5 1.55 10.6
Der1þSNV 20 5.02 98.8 17.3 3.44 20 2.63 96.3 11.7 1.56
Der1þMSC 5 9.33 95.7 30.9 1.80 9 7.07 73.1 44.1 0.49
SNV: standard normal variate transformation.
MSC: multiplicative scatter correction.
Der1: ﬁrst derivative.
Der2: second derivative.
The bold entry indicates the optimal spectral pretreatment (Der1).
Fig. 4. RMSEP versus the number of latent variables of the PLS regression: GABA
and L-Glu.
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ven period of time. In this process, most of the cost came from the
GAD super producer strain. Therefore, the total enzymatic activity
and the conversion time were selected as the two major factors in
determining the content of GABA (Y1). If the speciﬁed amount ofenzyme was introduced into the reaction system in a short period
of time, high initial GABA concentrations in the ﬁrst hour could
lead to a loss of control due to excess CO2. Therefore, the biomass
of the GAD producer strain had to be continually fed into the
bioreactor to control the CO2 production rate. The total amount of
time of enzyme addition was the third factor controlling the initial
GABA concentration (Y2).
According to the levels and factors of the Box-Behnken design
in Section 2.8, 17 Box-Behnken design experiments were per-
formed as listed in Table 4. The GABA content and the initial GABA
concentration were predicted by the PLS model in Section 3.3.
The results of the experiments listed in Table 4 were analyzed
using statistical analysis software to determine polynomial Eq. (5).
= + + – –
+ + – – – ( )
Y1 126.60 30.01A 21.17B 20.48C 18.29AB
22.71AC 18.04BC 29.52A 7.46B 6.04C 52 2 2
In the resulting polynomial equation, Y1 represents the response
value of GABA content (g/L), while A, B and C represent three
factors that inﬂuence the biotransformation process (total enzy-
matic activity, reaction time and total time of enzyme addition,
respectively).
Terms composed of two factors represent interaction terms,
and terms with second-order factors indicate the non-linear
nature of the relationship between the responses and the factors.
A positive sign indicates a synergistic effect, while a negative sign
represents an antagonistic effect [30]. This equation indicates that
Fig. 5. Predicted versus experimental values based on the validation set: (A) GABA and (B) L-Glu.
Table 4
The Box-Behnken experimental design with responses.
No. Total enzy-
matic
activity (U/L)
Reaction
time (h)
Total time
of enzyme
addition (h)
Y1: the
GABA
content
(g/L)
Y2: the initial
GABA concentra-
tion in the ﬁrst
hour (g/L)
1 13,320 5 3 120.62 31.38
2 3330 5 3 112.47 7.02
3 13,320 4 6 121.30 13.99
4 6660 4 3 129.40 11.98
5 13,320 4 1.5 117.22 79.03
6 6660 4 3 126.70 11.57
7 3330 4 6 17.45 5.60
8 6660 4 3 116.78 9.69
9 3330 4 3 121.40 10.28
10 3330 3 3 30.59 7.02
11 6660 4 3 115.68 13.56
12 3330 4 1.5 108.18 13.73
13 13,320 3 3 119.38 31.38
14 6660 5 1.5 128.42 27.44
15 6660 5 6 114.50 6.45
16 6660 3 6 31.38 6.45
17 6660 3 1.5 124.94 27.44
Fig. 6. Effects of total enzymatic activity and total time of enzyme addition o
G. Ding et al. / Journal of Pharmaceutical Analysis 6 (2016) 171–178176both total enzymatic activity and reaction time are positively re-
lated to the GABA content, indicating that increasing the reaction
time and total enzymatic activity might increase the GABA con-
version rate. The total time of enzyme addition was negatively
related to the GABA content, suggesting the rate of enzyme addi-
tion could promote biotransformation. As shown in Fig. 6, in-
creasing the enzymatic activity does not increase the GABA pro-
duction. After the reaction time was ﬁxed to 5 h, the total enzy-
matic activity was varied from 3330 to 13,320 U/L and the feeding
time was varied from 1.5 to 6 h to optimize GABA conversion. The
initial GABA concentration was held below 15 g/L during the ﬁrst
hour of the reaction. Enough enzyme provided at the right time
can avoid the production of high levels of CO2, improving the
biological conversion efﬁciency. According to Eq. (5), the best
condition was predicted to be 7148 U/L GAD enzymatic biomass
fed in 4.33 h, with the biotransformation of L-Glu reaching the
endpoint (499%) in the ﬁfth hour.
3.5. Monitoring the biotransformation process using on-line NIRS
model
To verify the reliability of the response surface model, a new batchn the GABA production. (A) Contour plot and (B) Response surface plot.
Fig. 7. Predicted and experimental values in the GABA biotransformation process.
G. Ding et al. / Journal of Pharmaceutical Analysis 6 (2016) 171–178 177biotransformation process was performed using the optimal para-
meters obtained in Section 3.4. After the ﬁrst 30 min, samples were
obtained every 10 min up to 450min. The L-Glu and GABA contents
were determined by the HPLC and NIRS methods, respectively.
Fig. 7 shows the predicted and true values for two different
compositions during the GABA biotransformation process. The L-
Glu concentration increased up to 240 min because of the con-
stantly increasing GABA concentration, which continuously in-
creased the pH, helping to dissolve the residual L-Glu, increasing
its concentration. After 240 min, the L-Glu concentration reached
its peak level, while the GABA concentration continued to steadily
increase. The biotransformation catalyzed by GAD occurred with-
out pH adjustment (pH ranged from 3.50 to 4.50), demonstrating
that the GAD maintains high catalytic activity over a wide range of
pH. As predicted by the response surface analysis, the reaction
reached a plateau at the ﬁfth hour, at which point the GABA
concentration reached 123 g/L.
The predicted and true L-Glu and GABA concentrations exhibited
similar variations over the entire biotransformation period. This de-
monstrated that the polynomial equations determined in the response
surface analysis exhibited good predictive ability. The RMSEP of these
equations were 1.58 and 3.07 g/L, respectively. All of these results
suggest that the calibration model has a good ability to predict L-Glu
(2.90–39.05 g/L) and GABA concentrations (2.01–123.41 g/L).4. Conclusions
Monitoring the concentrations of substrates and end products
in the bioreactor is important for the bioprocess control of GABA
biotransformation. On-line analysis provided straightforward
monitoring and rapid analysis after the samples were removed
from the bioreactor. NIRS shows promise as a rapid and non-de-
structive method for simultaneously determining the concentra-
tions of various compounds in the fermentation industry. Com-
pared with traditional chemical analyses, NIRS with a PLS model is
a rapid, versatile, inexpensive, and environmentally safe analytical
method for predicting compound concentrations.
The results of this work demonstrate that NIRS exhibits an
excellent predictive ability to monitor these concentrations in the
GABA biotransformation process, with an analysis time of
approximately 1 min. Therefore, on-line NIRS can be used to
control and optimize fermentation processes in real time. This
study combines the merits of NIRS with response surfacemethodology. NIRS not only enables real-time analysis but also
provides data to guide us towards the optimal biotransformation
conditions determined using response surface methodology.Acknowledgments
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